Armstrong Fleming & Moore’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,698
Closed -$226K 117
2026
Q1
$226K Buy
+2,698
New +$203K 0.1% 101
2025
Q3
Sell
-2,698
Closed -$201K 114
2025
Q2
$201K Buy
+2,698
New +$180K 0.11% 104

Other funds holding CTVA

Armstrong Fleming & Moore's CTVA Position: Q2 2026 in Review

Armstrong Fleming & Moore sold out of Corteva (CTVA) in Q2 2026, closing a stake of 2,698 shares — an estimated $226K sold.

Armstrong Fleming & Moore first reported a position in CTVA in Q2 2025 and held it in 2 quarters. The position peaked at $226K in Q1 2026. 1,491 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Armstrong Fleming & Moore reported no remaining Corteva position as of Q2 2026 after selling out during the quarter.
  • Armstrong Fleming & Moore sold 2,698 Corteva shares in Q2 2026, an estimated $226K.
  • Armstrong Fleming & Moore first reported a position in Corteva in Q2 2025 and held it in 2 quarters.
  • Armstrong Fleming & Moore's Corteva position peaked at $226K in Q1 2026.
  • 1,491 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Armstrong Fleming & Moore's 13F filing for Q2 2026, filed 28 Jul 2026.